ÐÓ°ÉÔ­´´

Klineo, based in Paris, is an AI-powered platform aimed at revolutionizing clinical trials through automation and optimization. Its B2B SaaS model addresses significant industry pain points like manual data entry, traditional monitoring methods, and inefficient software. By leveraging AI, Klineo seeks to accelerate trial completion times, reduce costs, and minimize errors, offering a substantial competitive edge. Supported by investors such as Pfizer Healthcare Hub: London, Bpifrance, and Wilco, Klineo is well-positioned to capture significant market share and drive innovation in clinical trials.